mrtx1133,sotorasib,atezolizumab
roche,amgen,mirati therapeutics
['sotorasib', 'atezo', 'mrtx1133']
janne #aacr23 a selective g12d inhibitor called mrtx1133, clinical trials in 2023. now onto combinations of ras inhibitors. not particularly effective. combined with ici - sotorasib plus atezolizumab, some liver toxicity.
Business development, marketing and sales professional in the life sciences, cancer diagnostics, and genomics fields. Blog: https://t.co/IeMzCogxlt. Opinions are my own.